 |
brigatinib |
|---|---|
| Trade Name | Alunbrig |
| Orphan Indication | Non-small cell lung cancer |
| USA Market Approval | USA |
| USA Designation Date | 2016-04-28 00:00:00 |
| Sponsor | ARIAD Pharmaceuticals, Inc.;26 Landsdowne Street;Cambridge, Massachusetts, 02139 |
Related Access Program